Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2W8N

The crystal structure of the oxidized form of human SSADH

Summary for 2W8N
Entry DOI10.2210/pdb2w8n/pdb
Related2W8O 2W8P 2W8Q 2W8R
DescriptorSUCCINATE-SEMIALDEHYDE DEHYDROGENASE, MITOCHONDRIAL, SULFATE ION (3 entities in total)
Functional Keywordsmitochondrion, oxidoreductase, transit peptide, disease mutation, ssa, nad, polymorphism, mitochondria
Biological sourceHOMO SAPIENS (HUMAN)
Cellular locationMitochondrion: P51649
Total number of polymer chains1
Total formula weight53059.15
Authors
Kim, Y.-G.,Kim, K.-J. (deposition date: 2009-01-19, release date: 2009-06-09, Last modification date: 2024-11-13)
Primary citationKim, Y.-G.,Lee, S.,Kwon, O.-S.,Park, S.-Y.,Lee, S.-J.,Park, B.-J.,Kim, K.-J.
Redox-Switch Modulation of Human Ssadh by Dynamic Catalytic Loop.
Embo J., 28:959-, 2009
Cited by
PubMed Abstract: Succinic semialdehyde dehydrogenase (SSADH) is involved in the final degradation step of the inhibitory neurotransmitter gamma-aminobutyric acid by converting succinic semialdehyde to succinic acid in the mitochondrial matrix. SSADH deficiency, a rare autosomal recessive disease, exhibits variable clinical phenotypes, including psychomotor retardation, language delay, behaviour disturbance and convulsions. Here, we present crystal structures of both the oxidized and reduced forms of human SSADH. Interestingly, the structures show that the catalytic loop of the enzyme undergoes large structural changes depending on the redox status of the environment, which is mediated by a reversible disulphide bond formation between a catalytic Cys340 and an adjacent Cys342 residues located on the loop. Subsequent in vivo and in vitro studies reveal that the 'dynamic catalytic loop' confers a response to reactive oxygen species and changes in redox status, indicating that the redox-switch modulation could be a physiological control mechanism of human SSADH. Structural basis for the substrate specificity of the enzyme and the impact of known missense point mutations associated with the disease pathogenesis are presented as well.
PubMed: 19300440
DOI: 10.1038/EMBOJ.2009.40
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon